---
title: Catalent vs Lonza Cell & Gene Technologies
slug_a: catalent
slug_b: lonza
site: cdmo
review_signal_gate: closed
canonical_path: /compare/catalent/lonza
generated_by: BioBM Editorial AI
---

# Catalent vs Lonza Cell & Gene Technologies

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Catalent (catalent) is listed for cdmo. Catalent provides CDMO services. Headquartered in US. Acquired by Novo Holdings in late 2024; integrated CDMO across modalities.

Services: 19. Modalities: 6. Indications: 0. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (19).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Lonza Cell & Gene Technologies (lonza) is listed for both. Lonza Cell & Gene Technologies provides CDMO services. Headquartered in CH.

Services: 12. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.